4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-26-000133
Executive Chair sold 26,756 shares at $72.00 ($1,926,432)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SAYER KEVIN R Executive Chair | 2026-07-06 | Sale 10b5-1 | −26,756 | $72.00 | $1,926,432 | 355,726 | D |
| Open-market sales · 26,756 sh · avg $72.00 · $1,926,432 | |||||||
Loading xslF345X06/wk-form4_1783454979.xml…